France· FR:61740809
RELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidose
A medicinal product containing furoate de fluticasone + trifénatate de vilantérol, registered in France by GLAXOSMITHKLINE TRADING SERVICES (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FUROATE DE FLUTICASONE + TRIFÉNATATE DE VILANTÉROL
- Manufacturer
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009276201021 plaquette(s) aluminium de 30 dose(s) - 1 plaquette(s) de 30 dose(s) avec inhalateur(s)EUR 28.38
- cip1334009302085403 plaquette(s) aluminium de 30 dose(s) avec inhalateur(s)EUR 84.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Furoate de fluticasone + trifénatate de vilantérol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a85581d-60d4-4dca-953e-2f81811b5aea GET /v1/drugs/4a85581d-60d4-4dca-953e-2f81811b5aea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61740809",
"date_amm": "2013-11-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/886",
"substance": "FUROATE DE FLUTICASONE + TRIFÉNATATE DE VILANTÉROL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et poudre pour inhalation",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about furoate de fluticasone + trifénatate de vilantérol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.